Background illustration for clinical trials search

Paid Clinical Trials Detroit

Discover 1,705 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

for
Low Grade Serous Ovarian Cancer
Location: Detroit MI, Cleveland OH, Hilliard OH, Pittsburgh PA,
Sponsor: Verastem, Inc.

Sex: Female

Age: 18+

Code: NCT06072781

Phase3, Recruiting

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Detroit MI, Ann Arbor MI, Cleveland OH, Baltimore MD,
Sponsor: Tvardi Therapeutics, Incorporated

Sex: All

Age: 18+

Code: NCT05440708

Phase1, Phase2, Recruiting

Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma

for
Multiple Myeloma
Location: Detroit MI, Lansing MI
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 18+

Code: NCT06107738

Phase2, Recruiting

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

for
AL Amyloidosis
Location: Detroit MI, Dearborn MI, Wyandotte MI, Brownstown MI,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06022939

Phase3, Recruiting

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

for
B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma,
Location: Detroit MI, Toronto, Buffalo NY, Bethesda MD,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT05006716

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

for
Cancer
Location: Detroit MI, Chicago IL, Fairfax VA, Philadelphia PA,
Sponsor: MBrace Therapeutics

Sex: All

Age: 18+

Code: NCT06014658

Phase1, Phase2, Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

for
High Grade Epithelial Ovarian Cancer,
Location: Detroit MI, Grand Rapids MI, Columbus OH, Pittsburgh PA,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT05579366

Phase1, Phase2, Recruiting

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Detroit MI, Columbus OH, Chicago IL, Philadelphia PA,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT04590326

Phase1, Phase2, Recruiting

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

for
T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma,
Location: Detroit MI, Ann Arbor MI, Pittsburgh PA, Chicago IL,
Sponsor: SciTech Development, Inc.

Sex: All

Age: 18+

Code: NCT04234048

Phase1, Recruiting

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

for
Metastatic Non Small Cell Lung Cancer
Location: Detroit MI, Columbus OH, Natrona Heights PA,
Sponsor: Iovance Biotherapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT04614103

Phase2, Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

for
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer,
Location: Detroit MI, Maumee OH, Buffalo NY, Cincinnati OH,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06881784

Phase3, Recruiting

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

for
Graft-versus-host Disease (GVHD)
Location: Detroit MI, Ann Arbor MI, Cleveland OH, Columbus OH,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06615050

Phase3, Recruiting

A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer

for
Pancreatic Ductal Adenocarcinoma
Location: Detroit MI, Houston TX
Sponsor: Oncotelic Inc.

Sex: All

Age: 18+

Code: NCT06079346

Phase2, Phase3, Recruiting

DapagliFLOzin in Renal AL Amyloidosis (FLORAL)

for
Renal AL Amyloidosis
Location: Detroit MI
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 18+

Code: NCT06420167

Phase2, Recruiting

C.A.P.A.B.L.E. (CrossFit® and Physical Activity: A Better Life Experience)

for
Cancer Survivors
Location: Detroit MI
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 18+

Code: NCT03750981

Recruiting

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

for
Multiple Myeloma
Location: Detroit MI, Pittsburgh PA, Buffalo NY, Chicago IL,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05201781

Recruiting

A Study of 177Lu-FAP-2286 in Advanced Solid Tumors

for
Solid Tumor
Location: Detroit MI, London, Toronto, Pittsburgh PA, Chicago IL,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT04939610

Phase1, Phase2, Recruiting

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Detroit MI, Farmington Hills MI, Flint MI, Lansing MI,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06500481

Phase3, Recruiting

A Study of ZL-1310 in Subjects With Small Cell Lung Cancer

for
SCLC
Location: Detroit MI, Cleveland OH, Pittsburgh PA, Buffalo NY,
Sponsor: Zai Lab (Shanghai) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06179069

Phase1, Recruiting

CAR-T Long Term Follow Up (LTFU) Study

for
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program,
Location: Detroit MI, Ann Arbor MI, Columbus OH, Hamilton,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 0 - 70+

Code: NCT02445222

Phase3, Recruiting